Fine Organic Q1 FY27 Results: EBITDA up 42%, PAT 46%

Strong start to FY27 for Fine Organic

Fine Organic Industries Limited reported a sharp improvement in operating performance for the quarter ended June 30, 2026 (Q1 FY27), with profitability rising faster than topline growth. On a consolidated basis, EBITDA jumped 42.4% year-on-year to 176.0 crore, while revenue from operations grew 18.0% to 694.2 crore. The company’s standalone performance was also strong, with profit after tax (PAT) rising 46.0% year-on-year to 135.5 crore on revenue growth of 19.5% to 668.07 crore.

The results were reviewed by the Audit Committee and approved by the Board of Directors at a meeting held on August 7, 2026. The financial statements were subject to a limited review by the statutory auditors, CNK & Associates LLP, which issued an unmodified conclusion.

Consolidated performance: revenue up, margins improve

In consolidated numbers, Fine Organic’s revenue from operations for Q1 FY27 came in at 694.2 crore versus 588.4 crore in Q1 FY26, translating into 18.0% year-on-year growth. Sequentially, revenue rose 11.0% from 625.3 crore in Q4 FY26.

Operating performance improved more sharply than revenue. Consolidated EBITDA rose to 176.0 crore from 123.6 crore a year ago, and from 129.8 crore in the previous quarter. This lifted the EBITDA margin to 25.3% in Q1 FY27 compared with 21.0% in Q1 FY26.

Consolidated profit: PAT rises 18% YoY

Consolidated PAT for the quarter rose to 138.1 crore in Q1 FY27 from 117.1 crore in Q1 FY26, a year-on-year increase of 18.0%. Compared with Q4 FY26 PAT of 117.5 crore, profit increased 17.6% quarter-on-quarter.

PAT margin was reported at 19.9% in Q1 FY27, unchanged from the year-ago quarter, and higher than 18.8% in Q4 FY26. Earnings per share (EPS) on a consolidated basis stood at 45.06 in Q1 FY27 versus 38.19 in Q1 FY26.

Standalone results: PAT up 46% on 19.5% revenue growth

On a standalone basis, Fine Organic reported revenue from operations of 668.07 crore for Q1 FY27, up 19.48% from 559.15 crore in Q1 FY26. Revenue also increased 8.40% sequentially from 616.30 crore in Q4 FY26.

Standalone PAT came in at 135.50 crore, compared with 92.83 crore in Q1 FY26, a rise of 45.97% year-on-year. The company also reported that standalone net profit increased 50.44% sequentially from 90.07 crore in Q4 FY26.

Income and expense snapshot for the quarter

The company’s standalone total income for Q1 FY27 was 691.69 crore, while total expenses were 508.53 crore. Profit before tax (PBT) was reported at 183.16 crore, and tax expenses were 47.20 crore, resulting in PAT of 135.50 crore.

Fine Organic also reported total comprehensive income of 145.70 crore for the quarter. Earnings per equity share (basic and diluted) on a standalone basis were 44.19.

What the margin expansion signals

The quarter’s key feature was the faster growth in EBITDA relative to revenue, particularly in the consolidated numbers where EBITDA rose 42.4% against revenue growth of 18.0%. The EBITDA margin moved up to 25.3% in Q1 FY27 from 21.0% a year ago.

The company commentary in the provided material points to improved pricing power and operational efficiency, even as raw material costs remained elevated. While the disclosures do not provide product-level mix or volume data in the excerpt, the combination of higher margins and solid revenue growth suggests improved operating leverage during the quarter.

Audit, approvals, and reporting timeline

Fine Organic stated that its unaudited standalone and consolidated results for the quarter ended June 30, 2026 were approved by the Board after an Audit Committee review. The statutory auditors, CNK & Associates LLP, carried out a limited review and issued an unmodified conclusion for both standalone and consolidated financial results.

For investors, this provides basic comfort around compliance and presentation, particularly since quarterly numbers are unaudited and rely on limited review procedures.

Market impact: what investors typically track from these results

The reported numbers highlight two clear themes: margin expansion and stable profit conversion. EBITDA margin improvement to 25.3% on a consolidated basis stands out because it came alongside an 18.0% year-on-year revenue increase. PAT margin at 19.9% on a consolidated basis was steady year-on-year and improved versus the previous quarter.

For the market, the near-term focus often shifts to whether this margin improvement is sustainable in an environment of elevated raw material costs, and whether the company can maintain pricing discipline without affecting demand. Another key monitorable from the disclosed data is the sequential improvement, with consolidated revenue up 11.0% QoQ and EBITDA up 35.5% QoQ.

Key financial metrics at a glance

Standalone versus consolidated: key Q1 FY27 disclosures

What to watch next

With Q1 FY27 showing higher operating profitability, the next set of updates investors typically look for includes commentary on input-cost trends, pricing actions, and the trajectory of operating margins. The disclosed sequential improvement versus Q4 FY26 will also place attention on whether the company can maintain momentum across subsequent quarters.

Any future board-approved updates, including the next quarterly earnings release and management commentary, will be key for interpreting how much of the margin expansion reflects one-quarter factors versus structural improvements.

Conclusion

Fine Organic Industries started FY27 with strong year-on-year growth in revenue and a sharper rise in EBITDA, supported by higher operating margins. The board-approved, limited-review results for the quarter ended June 30, 2026 show standalone PAT of 135.50 crore and consolidated PAT of 138.14 crore, with consolidated EBITDA at 176.0 crore. The next quarters will clarify how the company manages elevated raw material costs while sustaining the improved margin profile reported in Q1.